Sana Intidhar Labidi-Galy (S Intidhar Labidi-Galy, Intidhar Labidi-Galy)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Top Venues

Nature communications

Breast cancer research and treatment

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Sana Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle L Ray-Coquard
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma. Nature communications 15 (1) (2024)
Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Dogan, Ewa Gogola, Martín González Fernández, Alexandra Duarte, Jonas A Schmid, Morgane Decollogny, Paola Francica, Sara Przetocka, Stephen T Durant, Josep V Forment, Ismar Klebic, Myriam Siffert, Roebi de Bruijn, Arne N Kousholt, Nicole A Marti, Martina Dettwiler, Claus Storgaard Sørensen, Jean-Christophe Tille, Manuela Undurraga, Sana Intidhar Labidi-Galy, Massimo Lopes, Alessandro A Sartori, Jos Jonkers, Sven Rottenberg
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nature communications 15 (1) (2024)
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Sana Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle L Ray-Coquard
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma. Nature communications 15 (1) (2024)
Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Dogan, Ewa Gogola, Martín González Fernández, Alexandra Duarte, Jonas A Schmid, Morgane Decollogny, Paola Francica, Sara Przetocka, Stephen T Durant, Josep V Forment, Ismar Klebic, Myriam Siffert, Roebi de Bruijn, Arne N Kousholt, Nicole A Marti, Martina Dettwiler, Claus Storgaard Sørensen, Jean-Christophe Tille, Manuela Undurraga, Sana Intidhar Labidi-Galy, Massimo Lopes, Alessandro A Sartori, Jos Jonkers, Sven Rottenberg
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nature communications 15 (1) (2024)
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Sana Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle L Ray-Coquard
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma. Nature communications 15 (1) (2024)
Diego Dibitetto, Martin Liptay, Francesca Vivalda, Hülya Dogan, Ewa Gogola, Martín González Fernández, Alexandra Duarte, Jonas A Schmid, Morgane Decollogny, Paola Francica, Sara Przetocka, Stephen T Durant, Josep V Forment, Ismar Klebic, Myriam Siffert, Roebi de Bruijn, Arne N Kousholt, Nicole A Marti, Martina Dettwiler, Claus Storgaard Sørensen, Jean-Christophe Tille, Manuela Undurraga, Sana Intidhar Labidi-Galy, Massimo Lopes, Alessandro A Sartori, Jos Jonkers, Sven Rottenberg
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nature communications 15 (1) (2024)
Olivia Le Saux, Maude Ardin, Justine Berthet, Sarah Barrin, Morgane Bourhis, Justine Cinier, Yasmine Lounici, Isabelle Treilleux, Pierre-Alexandre Just, Guillaume Bataillon, Aude-Marie Savoye, Marie-Ange Mouret-Reynier, Elodie Coquan, Olfa Derbel, Louis Jeay, Suliman Bouizaguen, Sana Intidhar Labidi-Galy, Séverine Tabone-Eglinger, Anthony Ferrari, Emilie Thomas, Christine Ménétrier-Caux, Eric Tartour, Isabelle Galy-Fauroux, Marc-Henri Stern, Magali Terme, Christophe Caux, Bertrand Dubois, Isabelle L Ray-Coquard
Immunomic longitudinal profiling of the NeoPembrOv trial identifies drivers of immunoresistance in high-grade ovarian carcinoma. Nature communications 15 (1) (2024)
José L Sandoval, Sana Intidhar Labidi-Galy
Shallow whole genome re-sequencing to precisely predict benefit from PARP inhibitor. Oncogene (2023)
Lou Romanens, Prasad Chaskar, Rachel Marcone, Stephan Ryser, Jean-Christophe Tille, Raphael Genolet, Ketty Heimgartner-Hu, Killian Heimgartner, Jonathan S Moore, Nicolas Liaudet, Gürkan Kaya, Mikael J Pittet, Pierre-Yves Dietrich, Mauro Delorenzi, Daniel E Speiser, Alexandre Harari, Petros K Tsantoulis, Sana Intidhar Labidi-Galy
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics. International journal of cancer (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Judith Balmaña, Peter Andreas Fasching, Fergus J Couch, Suzette Delaloge, Sana Intidhar Labidi-Galy, Joyce O'Shaughnessy, Yeon Hee Park, Andrea F Eisen, Benoit You, Hughes Bourgeois, Anthony Goncalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena V Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V Timcheva, Tjoung-Won Park-Simon, A Anton Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A Gelmon, null null
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. Breast cancer research and treatment 204 (2) (2023)
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille, Pierre O Chappuis, Adrien Buisson, Sophie Giraud, Christine Lasset, Valerie Bonadona, Olivier Trédan, Sana Intidhar Labidi-Galy
Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Scientific reports 10 (1) (2020)
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean-Christophe Tille, Pierre O Chappuis, Adrien Buisson, Sophie Giraud, Christine Lasset, Valerie Bonadona, Olivier Trédan, Sana Intidhar Labidi-Galy
Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Scientific reports 10 (1) (2020)
Alex Friedlaender, Aurélie Vuilleumier, Valeria Viassolo, Aurélie Ayme, Solène De Talhouet, Jean-Damien Combes, Julien Peron, Alexandre Bodmer, Sophie Giraud, Adrien Buisson, Valerie Bonadona, Isabelle Gauchat-Bouchardy, Olivier Tredan, Pierre O Chappuis, Sana Intidhar Labidi-Galy
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. Breast cancer research and treatment 174 (3) (2019)
Kevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, Allison Vitonis, Leona A Doyle, Jason L Hornick, Gurkan Kaya, Laurent Barnes, Daniel W Cramer, Giacomo Puppa, Sarah Stuckelberger, Jagmohan Hooda, Pierre-Yves Dietrich, Michael G Goggins, Candace L Kerr, Michael Birrer, Michelle S Hirsch, Ronny Drapkin, Sana Intidhar Labidi-Galy
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors. The Journal of pathology 246 (4) (2018)